Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    November 2018
  1. JENSEN CT, Wagner-Bartak NA, Vu LN, Liu X, et al
    Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
    Radiology. 2018 Nov 27:181657. doi: 10.1148/radiol.2018181657.
    PubMed     Text format     Abstract available


  2. QI X, An W, Liu F, Qi R, et al
    Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
    Radiology. 2018 Nov 20:180425. doi: 10.1148/radiol.2018180425.
    PubMed     Text format     Abstract available


  3. MALAYERI AA
    Virtual Hepatic Venous Pressure Gradient with CT: Ready for Prime Time?
    Radiology. 2018 Nov 20:182351. doi: 10.1148/radiol.2018182351.
    PubMed     Text format    


  4. BASHIR MR, Chernyak V
    Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
    Radiology. 2018 Nov 13:182408. doi: 10.1148/radiol.2018182408.
    PubMed     Text format    


    October 2018
  5. YOON JH, Lee JM, Kang HJ, Ahn SJ, et al
    Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
    Radiology. 2018 Oct 30:180753. doi: 10.1148/radiol.2018180753.
    PubMed     Text format     Abstract available


  6. MOTOSUGI U, Roldan-Alzate A, Bannas P, Said A, et al
    Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.
    Radiology. 2018 Oct 16:180230. doi: 10.1148/radiol.2018180230.
    PubMed     Text format     Abstract available


  7. KHALAF MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, et al
    A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Radiology. 2018 Oct 9:180257. doi: 10.1148/radiol.2018180257.
    PubMed     Text format     Abstract available


    September 2018
  8. CHERNYAK V, Fowler KJ, Kamaya A, Kielar AZ, et al
    Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Radiology. 2018 Sep 25:181494. doi: 10.1148/radiol.2018181494.
    PubMed     Text format     Abstract available


  9. FLETCHER JG, Fidler JL, Venkatesh S, Hough DM, et al
    Observer Performance with Varying Radiation Dose and Reconstruction Methods for Detection of Hepatic Metastases.
    Radiology. 2018 Sep 11:180125. doi: 10.1148/radiol.2018180125.
    PubMed     Text format     Abstract available


  10. SARTORIS R, Rautou PE, Elkrief L, Pollorsi G, et al
    Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
    Radiology. 2018 Sep 4:181131. doi: 10.1148/radiol.2018181131.
    PubMed     Text format     Abstract available


    August 2018
  11. PANDEY A, Pandey P, Ghasabeh MA, Zarghampour M, et al
    Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
    Radiology. 2018 Aug 21:180450. doi: 10.1148/radiol.2018180450.
    PubMed     Text format     Abstract available


    July 2018
  12. BARR RG
    Liver Elastography Still in Its Infancy.
    Radiology. 2018;288:107-108.
    PubMed     Text format    


  13. HUDERT CA, Tzschatzsch H, Guo J, Rudolph B, et al
    US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Radiology. 2018;288:99-106.
    PubMed     Text format     Abstract available


    June 2018
  14. LUETKENS JA, Klein S, Traber F, Schmeel FC, et al
    Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.
    Radiology. 2018 Jun 26:180051. doi: 10.1148/radiol.2018180051.
    PubMed     Text format     Abstract available


  15. JOHNSON PT, Fishman EK
    Hereditary Hemorrhagic Telangiectasia: Cinematic Rendering of Hepatic Arteriovenous Malformations.
    Radiology. 2018 Jun 19:180380. doi: 10.1148/radiol.2018180380.
    PubMed     Text format    


  16. HEVERHAGEN JT, Kudrnova S
    Subcentimeter Hepatocellular Carcinoma: A New Paradigm for Treatment with Percutaneous Radiofrequency Ablation?
    Radiology. 2018 Jun 19:180977. doi: 10.1148/radiol.2018180977.
    PubMed     Text format    


  17. SONG KD, Lee MW, Rhim H, Kang TW, et al
    Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Radiology. 2018 Jun 19. doi: 10.1148/radiol.2018172743.
    PubMed     Text format     Abstract available


  18. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    PubMed     Text format     Abstract available


  19. FANG C, Jaffer OS, Yusuf GT, Konstantatou E, et al
    Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice.
    Radiology. 2018;287:844-852.
    PubMed     Text format     Abstract available


  20. TROUT AT, Sheridan RM, Serai SD, Xanthakos SA, et al
    Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.
    Radiology. 2018;287:824-832.
    PubMed     Text format     Abstract available


    May 2018
  21. BARABASCH A, Heinzel A, Bruners P, Kraemer NA, et al
    Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing (90)Y Radioembolization of Hepatic Metastases.
    Radiology. 2018 May 21:170408. doi: 10.1148/radiol.2018170408.
    PubMed     Text format     Abstract available


  22. DEVULAPALLI KK, Fidelman N, Soulen MC, Miller M, et al
    (90)Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
    Radiology. 2018 May 8:170962. doi: 10.1148/radiol.2018170962.
    PubMed     Text format     Abstract available


  23. JONDAL DE, Thompson SM, Butters KA, Knudsen BE, et al
    Heat Stress and Hepatic Laser Thermal Ablation Induce Hepatocellular Carcinoma Growth: Role of PI3K/mTOR/AKT Signaling.
    Radiology. 2018 May 8:172944. doi: 10.1148/radiol.2018172944.
    PubMed     Text format     Abstract available


  24. CROCETTI L
    Radiofrequency Ablation versus Resection for Small Hepatocellular Carcinoma: Are Randomized Controlled Trials Still Needed?
    Radiology. 2018;287:473-475.
    PubMed     Text format    


  25. POMPER MG, Lee S
    Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.
    Radiology. 2018;287:590-591.
    PubMed     Text format    


    April 2018
  26. SOFOCLEOUS CT, Boas FE
    Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?
    Radiology. 2018 Apr 24:180163. doi: 10.1148/radiol.2018180163.
    PubMed     Text format    


  27. LEWANDOWSKI RJ, Gabr A, Abouchaleh N, Ali R, et al
    Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.
    Radiology. 2018 Apr 24:171768. doi: 10.1148/radiol.2018171768.
    PubMed     Text format     Abstract available


  28. ZHU K, Huang J, Lai L, Huang W, et al
    Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Apr 24:172028. doi: 10.1148/radiol.2018172028.
    PubMed     Text format     Abstract available


  29. CERNY M, Bergeron C, Billiard JS, Murphy-Lavallee J, et al
    LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features.
    Radiology. 2018 Apr 10:171678. doi: 10.1148/radiol.2018171678.
    PubMed     Text format     Abstract available


  30. SHYN PB, Casadaban LC, Sainani NI, Sadow CA, et al
    Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Radiology. 2018 Apr 3:172108. doi: 10.1148/radiol.2018172108.
    PubMed     Text format     Abstract available


  31. WANG X, Su Z, Lyu T, Figini M, et al
    (18)F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
    Radiology. 2018;287:137-145.
    PubMed     Text format     Abstract available


    March 2018
  32. MULE S, Thiefin G, Costentin C, Durot C, et al
    Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.
    Radiology. 2018 Mar 27:171320. doi: 10.1148/radiol.2018171320.
    PubMed     Text format     Abstract available


  33. PANDEY A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, et al
    Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
    Radiology. 2018 Mar 27:171593. doi: 10.1148/radiol.2018171593.
    PubMed     Text format     Abstract available


  34. TA CN, Kono Y, Eghtedari M, Oh YT, et al
    Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings.
    Radiology. 2018;286:1062-1071.
    PubMed     Text format     Abstract available


    February 2018
  35. CHOI SH, Byun JH, Lim YS, Lee SJ, et al
    Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.
    Radiology. 2018 Feb 19:170748. doi: 10.1148/radiol.2018170748.
    PubMed     Text format     Abstract available


  36. PENG Z, Chen S, Wei M, Lin M, et al
    Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Radiology. 2018 Feb 1:171541. doi: 10.1148/radiol.2018171541.
    PubMed     Text format     Abstract available


  37. MURALI N, Laage-Gaupp FM, Chapiro J, Geschwind JF, et al
    Science to Practice: Decrypting the Enigma of Ablation-induced Off-Target Effects-Is Network Pathway Analysis the Final Piece of the Puzzle?
    Radiology. 2018;286:405-408.
    PubMed     Text format     Abstract available


  38. BOESCH C
    Quantitative MR Imaging Is Increasingly Important in Liver Disease.
    Radiology. 2018;286:557-559.
    PubMed     Text format    


    January 2018
  39. KWEE SA, Wong L, Chan OTM, Kalathil S, et al
    PET/CT with (18)F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.
    Radiology. 2018 Jan 9:171333. doi: 10.1148/radiol.2018171333.
    PubMed     Text format     Abstract available


  40. LEE DH, Lee JM, Kang TW, Rhim H, et al
    Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.
    Radiology. 2018;286:338-349.
    PubMed     Text format     Abstract available


    December 2017
  41. YU SCH, Chan SL, Lee KF, Hui JWY, et al
    Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.
    Radiology. 2017 Dec 22:170154. doi: 10.1148/radiol.2017170154.
    PubMed     Text format     Abstract available


  42. YASAKA K, Akai H, Kunimatsu A, Abe O, et al
    Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Radiology. 2017 Dec 14:171928. doi: 10.1148/radiol.2017171928.
    PubMed     Text format     Abstract available


  43. SANDOW TA, Arndt SE, Albar AA, DeVun DA, et al
    Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort.
    Radiology. 2017 Dec 4:170731. doi: 10.1148/radiol.2017170731.
    PubMed     Text format     Abstract available


  44. SHAMIR SB, Kurian J, Kogan-Liberman D, Taragin BH, et al
    Hepatic Imaging in Neonates and Young Infants: State of the Art.
    Radiology. 2017;285:763-777.
    PubMed     Text format     Abstract available


  45. YANG X
    Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.
    Radiology. 2017;285:699-701.
    PubMed     Text format     Abstract available


  46. WHITE SB, Kim DH, Guo Y, Li W, et al
    Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
    Radiology. 2017;285:809-819.
    PubMed     Text format     Abstract available


    November 2017
  47. CHOI SY, Kim SH, Park CK, Min JH, et al
    Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Radiology. 2017 Nov 21:162846. doi: 10.1148/radiol.2017162846.
    PubMed     Text format     Abstract available


  48. TANG A, Bashir MR, Corwin MT, Cruite I, et al
    Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Radiology. 2017 Nov 21:170554. doi: 10.1148/radiol.2017170554.
    PubMed     Text format     Abstract available


  49. FARRAR CT, Gale EM, Kennan R, Ramsay I, et al
    CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis.
    Radiology. 2017 Nov 20:170595. doi: 10.1148/radiol.2017170595.
    PubMed     Text format     Abstract available


  50. XU XL, Liu XD, Liang M, Luo BM, et al
    Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.
    Radiology. 2017 Nov 13:162756. doi: 10.1148/radiol.2017162756.
    PubMed     Text format     Abstract available


  51. SEROR O, Nault JC, N'Kontchou G, Sutter O, et al
    Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental 90Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?
    Radiology. 2017;285:690-691.
    PubMed     Text format    


  52. ADAM LC, Murali N, Chapiro J, Geschwind JF, et al
    Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?
    Radiology. 2017;285:333-335.
    PubMed     Text format     Abstract available


  53. YAN F, Wang S, Yang W, Goldberg SN, et al
    Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Radiology. 2017;285:462-471.
    PubMed     Text format     Abstract available


  54. FOWLER KJ, Tang A, Santillan C, Bhargavan-Chatfield M, et al
    Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
    Radiology. 2017 Nov 1:170376. doi: 10.1148/radiol.2017170376.
    PubMed     Text format     Abstract available


    October 2017
  55. YASAKA K, Akai H, Abe O, Kiryu S, et al
    Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.
    Radiology. 2017 Oct 27:170706. doi: 10.1148/radiol.2017170706.
    PubMed     Text format     Abstract available


    September 2017
  56. WANG WT, Yang L, Yang ZX, Hu XX, et al
    Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.
    Radiology. 2017 Sep 22:170515. doi: 10.1148/radiol.2017170515.
    PubMed     Text format     Abstract available


  57. RUNGE JH, Smits LP, Verheij J, Depla A, et al
    MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Radiology. 2017 Sep 15:162931. doi: 10.1148/radiol.2017162931.
    PubMed     Text format     Abstract available


  58. YOKOO T, Serai SD, Pirasteh A, Bashir MR, et al
    Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
    Radiology. 2017 Sep 11:170550. doi: 10.1148/radiol.2017170550.
    PubMed     Text format     Abstract available


  59. KUMAR G, Goldberg SN, Gourevitch S, Levchenko T, et al
    Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
    Radiology. 2017 Sep 6:162943. doi: 10.1148/radiol.2017162943.
    PubMed     Text format     Abstract available


    August 2017
  60. FRAUM TJ, Tsai R, Rohe E, Ludwig DR, et al
    Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
    Radiology. 2017 Aug 29:170114. doi: 10.1148/radiol.2017170114.
    PubMed     Text format     Abstract available


  61. DISTELMAIER M, Barabasch A, Heil P, Kraemer NA, et al
    Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Radiology. 2017 Aug 11:161561. doi: 10.1148/radiol.2017161561.
    PubMed     Text format     Abstract available


  62. RONALD J, Nixon AB, Marin D, Gupta RT, et al
    Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
    Radiology. 2017 Aug 8:162555. doi: 10.1148/radiol.2017162555.
    PubMed     Text format     Abstract available


  63. WAGNER M, Corcuera-Solano I, Lo G, Esses S, et al
    Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study.
    Radiology. 2017;284:401-412.
    PubMed     Text format     Abstract available


    July 2017
  64. LV Y, He C, Wang Z, Guo W, et al
    Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
    Radiology. 2017 Jul 5:162266. doi: 10.1148/radiol.2017162266.
    PubMed     Text format     Abstract available


  65. LEE JM
    Old and New MR Tools to Measure Hepatic Steatosis: Is Their Diagnostic Accuracy the Same?
    Radiology. 2017;284:303-304.
    PubMed     Text format    


  66. HARZ C, Schockel L, Endrikat J, Pietsch H, et al
    Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.
    Radiology. 2017;284:299-301.
    PubMed     Text format    


    June 2017
  67. KIM BR, Lee JM, Lee DH, Yoon JH, et al
    Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
    Radiology. 2017 Jun 13:162080. doi: 10.1148/radiol.2017162080.
    PubMed     Text format     Abstract available


  68. LEE DH, Lee JY, Lee KB, Han JK, et al
    Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy.
    Radiology. 2017 Jun 13:161923. doi: 10.1148/radiol.2017161923.
    PubMed     Text format     Abstract available


  69. GOSHIMA S, Bae KT
    Liver Surface Nodularity as a Biomarker for Detection and Evaluation of Cirrhosis.
    Radiology. 2017;283:921-922.
    PubMed     Text format    


  70. CHEN BB, Hsu CY, Yu CW, Liang PC, et al
    Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Radiology. 2017;283:923.
    PubMed     Text format    


  71. SAVIC LJ, Chapiro J, Geschwind JF
    Science to Practice: Killing Dormant Cells-Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?
    Radiology. 2017;283:621-623.
    PubMed     Text format     Abstract available


  72. GARCOVICH M, Veraldi S, Di Stasio E, Zocco MA, et al
    Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.
    Radiology. 2017;283:820-827.
    PubMed     Text format     Abstract available


    May 2017
  73. KAO WY, Su CW, Chiou YY, Chiu NC, et al
    Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
    Radiology. 2017 May 30:162382. doi: 10.1148/radiol.2017162382.
    PubMed     Text format     Abstract available


  74. WIDYA RL, de Mutsert R, Westenberg JJM, Gast KB, et al
    Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study.
    Radiology. 2017 May 29:160916. doi: 10.1148/radiol.2017160916.
    PubMed     Text format     Abstract available


  75. LEE KS, Santagostino SF, Li D, Ramjit A, et al
    Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.
    Radiology. 2017 May 11:162617. doi: 10.1148/radiol.2017162617.
    PubMed     Text format     Abstract available


  76. KUHN JP, Meffert P, Heske C, Kromrey ML, et al
    Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Radiology. 2017 May 5. doi: 10.1148/radiol.2017161228.
    PubMed     Text format     Abstract available


    April 2017
  77. SUTTER O, Calvo J, N'Kontchou G, Nault JC, et al
    Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Radiology. 2017 Apr 28:161413. doi: 10.1148/radiol.2017161413.
    PubMed     Text format     Abstract available


  78. CHEN R, Li J, Zhou X, Liu J, et al
    Fructose-1,6-Bisphosphatase 1 Reduces 18F FDG Uptake in Hepatocellular Carcinoma.
    Radiology. 2017 Apr 6:161607. doi: 10.1148/radiol.2017161607.
    PubMed     Text format     Abstract available


  79. ETCHELL E, Juge L, Hatt A, Sinkus R, et al
    Liver Stiffness Values Are Lower in Pediatric Subjects than in Adults and Increase with Age: A Multifrequency MR Elastography Study.
    Radiology. 2017;283:222-230.
    PubMed     Text format     Abstract available


    March 2017
  80. PULLI B, Wojtkiewicz G, Iwamoto Y, Ali M, et al
    Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Radiology. 2017 Mar 30:160588. doi: 10.1148/radiol.2017160588.
    PubMed     Text format     Abstract available


  81. PARK MJ, Hong N, Han K, Kim MJ, et al
    Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Radiology. 2017 Mar 22:161619. doi: 10.1148/radiol.2017161619.
    PubMed     Text format     Abstract available


    February 2017
  82. HYODO T, Yada N, Hori M, Maenishi O, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation.
    Radiology. 2017 Feb 17:160130. doi: 10.1148/radiol.2017160130.
    PubMed     Text format     Abstract available


  83. SOLOMON J, Marin D, Roy Choudhury K, Patel B, et al
    Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Rec
    Radiology. 2017 Feb 7:161736. doi: 10.1148/radiol.2017161736.
    PubMed     Text format     Abstract available


  84. MICHEL LS, Dyroff S, Brooks FJ, Spayd KJ, et al
    PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies.
    Radiology. 2017;282:453-463.
    PubMed     Text format     Abstract available


    December 2016
  85. KIM YK, Lin WC, Sung K, Raman SS, et al
    Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
    Radiology. 2016 Dec 15:160241.
    PubMed     Text format     Abstract available


  86. BELLINI D, Ramirez-Giraldo JC, Bibbey A, Solomon J, et al
    Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation.
    Radiology. 2016 Dec 5:161233.
    PubMed     Text format     Abstract available


    November 2016
  87. SAHU S, Schernthaner R, Ardon R, Chapiro J, et al
    Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?
    Radiology. 2016 Nov 10:160838.
    PubMed     Text format     Abstract available


    October 2016
  88. SERAI SD, Dillman JR, Trout AT
    Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Young Adults Suspected of Having Liver Disease.
    Radiology. 2016 Oct 10:160589.
    PubMed     Text format     Abstract available


    August 2016
  89. HYODO T, Hori M, Lamb P, Sasaki K, et al
    Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.
    Radiology. 2016 Aug 19:160129.
    PubMed     Text format     Abstract available


    June 2016
  90. TROUT AT, Serai S, Mahley AD, Wang H, et al
    Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences.
    Radiology. 2016 Jun 10:160209.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: